Cargando…
Nano-vectors for the Ocular Delivery of Nucleic Acid-based Therapeutics
Nucleic acid-based therapeutics have gained a lot of interest for the treatment of diverse ophthalmic pathologies. The first to enter in clinic has been an oligonucleotide, Vitravene(®) for the treatment of cytomegalovirus infection. More recently, research on aptamers for the treatment of age relat...
Autores principales: | Khar, R. K., Jain, G. K., Warsi, M. H., Mallick, N., Akhter, S, Pathan, S. A., Ahmad, F. J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3178967/ https://www.ncbi.nlm.nih.gov/pubmed/21969738 http://dx.doi.org/10.4103/0250-474X.84575 |
Ejemplares similares
-
Cationic Liposomes as Vectors for Nucleic Acid and Hydrophobic Drug Therapeutics
por: Ewert, Kai K., et al.
Publicado: (2021) -
Gold Nanoparticles for Vectorization of Nucleic Acids for Cancer Therapeutics
por: Ferreira, Daniela, et al.
Publicado: (2020) -
Non-Viral Vectors for Delivery of Nucleic Acid Therapies for Cancer
por: Kanvinde, Shrey, et al.
Publicado: (2022) -
Delivery of nucleic acid therapeutics for cancer immunotherapy
por: Zhou, Shurong, et al.
Publicado: (2020) -
Nanoparticles laden in situ gel for sustained ocular drug delivery
por: Gupta, Himanshu, et al.
Publicado: (2013)